Skip to content
Search AI Powered

Latest Stories

Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Hall of Flowers (HOF) made its New York debut with a clean, trade-first show that fostered deeper conversations over spectacle. With a buyers-only opening day and tight credentialing, the floor moved at a measured pace, ideal for discovery and deal-making.

Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Hall of Flowers NYC Debut: Cali Vibes Minus the Pulse of NY Cannabis

Photo courtesy of Hall of Flowers

Upon entering through the doors at Pier 36 it was refreshing to see row after row of identical booths, neat as a spreadsheet, designed to let the product speak for itself. Buyers drifted through the aisles with line sheets instead of selfie sticks, the volume dialed way down compared to last month's Revelry event at the same location. And, maybe that was the point. Hall of Flowers’ first New York edition was designed for commerce, not commotion: a buyers-only opening day, tight credentialing, a controlled environment and pace that favored real conversations over spectacle.

The uniformity of Hall of Flowers' format erased the booth-flex arms race; most of the brands stood shoulder-to-shoulder on product, pricing, and execution. “Much easier to have conversations here than at Revelry,” several attendees told us. Others called it “weak” or “quiet” by comparison. One marketing exec involved in the event went all in saying, “Revelry is a flea market compared to Hall of Flowers.” What he meant by that is: Hall of Flowers is a curated, high-end trade event, whereas Revelry functions more as a community marketplace. I could see his point.


Multi-state polish, East Coast reality

By mid-day, you could feel the gravitational pull of the many out-of-state companies, brands and people. California heavyweights showed up to stake a claim: Alien Labs/Connected teased their New York play via Fluent; Jetty lined up buyers with a tidy, retail-ready menu. For extract lovers, a Royal Leaf (NY) × Kalya (CA) rosin tease felt like the kind of cross-coastal uplift New York’s concentrate set has been waiting for.

Not to be outdone, Massachusetts cannabis also showed up in force. Curaleaf which has several (formerly-medical) retail locations in NY already, showcased some of it's latest and greatest. Northampton's Melt-to-Make was looking to expand the reach for its gummy bases that simplify the process of manufacturing all-natural gummies. Jason Reposa from Good Feels was making the rounds, as were Nova Farms and Nimbus Cannabis Co., among others.

What New York had to show for itself

Even with the Multi-state attention, several New York outfits cut through precisely because the floor was calm:

  • CannaPrints was an interesting innovation turning cannabinoids into dissolvable (edible) tabs and infused rolling papers. A small sublingual reminiscent of sacremental bread/eucharist, just infused. Which begs the question: What would Jesus Do?
  • Electraleaf continued to showcase its music-meets-street aesthetic with a menu that’s actually ready for shelves—vapes, five-packs, classic eighths—the sort of line a retail buyer can slot tomorrow.
  • Boukét played the brand story game flawlessly, modernizing a slice of New York history (“bouquet” as a Harlem code word) into giftable, premium-leaning products and packaging that moves on sight as much as on spec.
  • Canna Cure Farms brought the sun-grown sermon without the sermon, slow-dried, carefully cured flower that lets terps do the talking. In a potency-obsessed market, that education arc matters.
  • Jenny’s (Jenny Loves Me) covered the wellness flank, sugar-free, kosher, vegan edibles built for dietary constraints, plus hash-resin vapes and petite pre-rolls for the “real weed, cleaner inputs” crowd.
  • Nanticoke offered something buyers always ask for and rarely get: a scalable, greenhouse-grown, in-state supply that can carry everyday price tiers without feeling like compromise.

None of these plays needed a 20-foot truss to make the case. On a level floor, they stood out on their own merits.

Two events, one thriving ecosystem

Comparisons to Revelry were inevitable. Revelry’s Buyers’ Club has become the heartbeat of New York’s legal market with 300+ licensed retailers and 200+ brands under one roof, the culture loud and the pace relentless - just like the city that never sleeps. Hall of Flowers is more "craft fair": quieter, credentialed, built for deliberate and intentional marketing and sales that go from “nice to meet you” to “send the follow-up” in real time. The market is clearly healthy enough for both events, however it's this writers personal opinion that each should consider 'collaboration over competition', where these two competing events can shine as one, at least here in NY.

It's also worth noting that on the eve of the event, the Office of Cannabis Management emailed licensees warning that Hall of Flowers might involve on-site consumption and indirect retail sales, and that participating in an “unpermitted cannabis event” could trigger penalties under 9 NYCRR Parts 120 and 133. The notice spooked the ecosystem: several NY licensees told us they skipped the show entirely, and others pared back staff rather than risk a paperwork misread or risking their license. On the floor, though, HOF ran a tight, trade-only program, buyers-first scheduling, credential checks, and sampling confined to appropriate licensees. Organizers and attendees described operations as above board; the notice read more like a blanket, cover-your-asses advisory than an actionable violation. The effect was real - the room was quieter than it might have been, but the sky did not fall for those exhibiting and in attendance.

- YouTube www.youtube.com

What remains after the badges come off

  • Designing for decisions works. A buyers-first schedule and uniform builds kept attention on product, price, and plans—not flash.
  • Cross-state collabs are the fastest upgrade path. If Royal Leaf × Kalya is a preview, rosin buyers finally have something premium to point at—made here, influenced there.
  • New York still rewards authenticity. Out-of-state polish draws the crowd; New York provenance sets the tone and pace.

Bottom line: If Revelry captures the soul of New York cannabis community + culture, Hall of Flowers arrived as its sober counterpart, Cali vibes, yes, but disciplined, transactional, and oddly sufficient.

More For You

Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less
Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
a crudely rolled lit joint being passed to camera
Photo by Chase Fade on Unsplash

Alcohol vs Marijuana: Alcohol Worse?

Turns out, your friend who swapped tequila shots for THC gummies might be on to something. A new poll has found that a majority of Americans now believe alcohol is more harmful to a person’s health than marijuana—and frankly, it’s about time. The severe health risks associated with alcohol use, including addiction, various diseases, and a high incidence of mortality, are becoming more widely recognized.

The survey, conducted by YouGov, asked over 1,000 U.S. adults to weigh in on which substance does more damage: good ol’ booze or that plant that’s still somehow federally illegal. The verdict? 64% of respondents said alcohol is more dangerous, compared to just 27% who pointed the finger at weed. The rest? They couldn’t decide or didn’t care enough to pick.

Keep ReadingShow less
image of a circle of doctors and surgeons standing over and looking at a patient on operating room table
New Study Confirms Medical Cannabis Benefits in Cancer Care—Time for Policy to Catch Up
Photo by National Cancer Institute on Unsplash

Cannabis & Cancer: The Evidence Is In—So Why Is the Medical Establishment Still Dragging Its Feet?

If you've ever watched a loved one battle cancer—or been on that journey yourself—you already know the harsh truth: the pain is real, the nausea is relentless, the appetite is gone, and the side effects of treatment often feel worse than the disease. So when patients say cannabis helps, it shouldn’t take 10,000 studies for the medical community to take them seriously.

And yet, here we are.

Keep ReadingShow less
image of California coast, pacific coast highway at sunset
How Overregulation Crushed California’s Gold Flora—And Why Other States Should Be Worried
Photo by Matthew Hamilton on Unsplash

Overregulation Kills Gold Flora

When California-based Gold Flora entered the legal cannabis scene, the company was poised to dominate. Backed by serious money and a sprawling, vertically integrated operation—from a 100,000-square-foot cultivation campus in the desert to marquee dispensaries in West Hollywood and San Jose—Gold Flora wasn't just riding the green wave. It was supposed to be the wave.

But by the end of March 2025, the company had filed for receivership, its assets now headed to auction. And while headlines cite "merger woes" and "market conditions," the real culprit behind Gold Flora’s collapse is far more systemic: a regulatory stranglehold that has quietly choked the life out of California’s once-promising cannabis economy.

Keep ReadingShow less